Foundation News

Please read through this section of our website to learn more about what's "new" at the Foundation.
 
Prostate Cancer Canada awards “Plaid Vest” to Winnipeg’s Arnold Bros. Transport Ltd., the 2018 Plaid for Dad National Workplace Champion

WINNIPEG, MB (August 16, 2018) – Prostate Cancer Canada is pleased to congratulate Winnipeg-based Arnold Bros. Transport Ltd. and honour its team with the coveted “Plaid Vest” award for its outstanding efforts raising funds and awareness during the Plaid for Dad fundraiser. The group raised over $19,000, and wrapped one of its tractor-trailers in plaid to take the message to the streets.

Prostate Cancer Canada launches first national program in radionuclide therapy

Toronto, June 27, 2018 – Canadian researchers are leading the future of treatment for men with advanced prostate cancer in this country, with a new Prostate Cancer Canada grant funded by the Movember Foundation. The National Program on Targeted Radionuclide Therapy for Prostate Cancer focuses on radionuclide therapy (RNT): a new form of treatment for men with advanced prostate cancer which cannot be cured by current methods. This coordinated, national initiative aims to accelerate access to this promising and innovative treatment for Canadian men.

Honouring dad this Father’s Day the Canadian way: In plaid

TORONTO, ON – (May 8, 2018) – Plaid replaces business-casual on Friday, June 15 as hundreds of thousands of Canadians don the iconic Canadian attire all to honour dad and end prostate cancer. The nationwide Prostate Cancer Canada fundraiser and awareness campaign sees scores of workplaces and individuals changing the lives of the one in seven Canadian men who will be diagnosed with the disease.

The Finger – A tried and true method to save lives

TORONTO, CANADA (May 8, 2018) – Every day, more and more methods to detect prostate cancer are being explored, but the tried and true methods of a digital rectal examination (DRE) – where a healthcare professional inserts a gloved finger into the rectum to check for abnormalities, paired with a blood test known as the prostate-specific antigen (PSA) test – which you can get through your family doctor, are still the long-standing proven ways to save a life.

Landmark study links tumour evolution to prostate cancer severity

Toronto (April 19, 2018) – Findings from Canadian Prostate Cancer Genome Network (CPC-GENE) researchers and their collaborators, published today in Cell, show that the aggressiveness of an individual prostate cancer can be accurately assessed by looking at how that tumour has evolved. This information can be used to determine what type and how much treatment should be given to each patient, or if any is needed at all.

Can exercise help slow prostate cancer growth?

Toronto, March 12, 2018 – Funded by Prostate Cancer Canada (PCC), Dr. Kerry Courneya’s team at the University of Alberta will study whether exercise can reduce tumour growth and anxiety for men on active surveillance.  

Prostate Cancer Canada’s Rock the Road Raffle sells out for 5th consecutive year

February 23, 2018 – TORONTO, ON – For the fifth year and counting, Prostate Cancer Canada’s (PCC) Rock the Road Raffle brought together Ontarians from all walks of life to both support an important cause and gain a chance to win a one-of-a-kind dream car.

Do men’s toenails contain clues about prostate cancer prevention?

Toronto, January 29, 2018 – Funded by Prostate Cancer Canada (PCC), Dr. Anil Adisesh at Dalhousie Medicine New Brunswick, Dalhousie University, and Dr. Trevor Dummer at the Centre of Excellence in Cancer Prevention, within the School of Population and Public Health at the University of British Columbia, will lead a team analyzing the world’s largest collection of toenails, all from Atlantic Canadians, to measure individual exposures to toxic metals that are known carcinogens and may cause prostate cancer. This research is part of a wider strategy by PCC to generate new and practical knowledge in the poorly understood area of prostate cancer prevention.  

Discovery of a promising new medication to block 'master key' of cancer growth

Vancouver, BC – For years, researchers have investigated approaches to prevent cancer-causing cells from multiplying in the body. Now, Vancouver Prostate Centre (VPC) scientist Dr. Christopher Ong and colleagues have discovered a critical gene that drives cancer growth. From this discovery, they developed a new protein-based medication that prevents unhealthy cell growth that leads to prostate cancer, and potentially other cancers.   Dr. Ong shows support for Prostate Cancer Canada's annual Plaid for Dad fundraiser

RFP: Content Development and Delivery of an Accredited Electronic Continuing Medical Education Course for Prostate Cancer Specialists

Prostate Cancer Canada invites applications from service providers interested in the development, promotion and delivery of an accredited electronic Continuing Medical Education course targeting prostate cancer specialists, including urologists. The course will be made available in both English and French. The anticipated start date of the course will be April 2018 and the course will be made available for one year after launch. 

Displaying results 1-10 (of 143)
 |<  < 1 - 2 - 3 - 4 - 5 - 6 - 7 - 8 - 9 - 10  >  >| 

Prostate Cancer Awareness Month

Donate Now!


Subscribe to our free monthly e-newsletter!

* indicates required

 





 
PCC Spotlight
Prostate Cancer Canada launches first national program in radionuclide therapy

Toronto, June 27, 2018 – Canadian researchers are leading the future of treatment for men with advanced prostate cancer in this country, with a new Prostate Cancer Canada grant funded by the Movember Foundation.
More

Honouring dad this Father’s Day the Canadian way: In plaid

TORONTO, ON – (May 8, 2018) – Plaid replaces business-casual on Friday, June 15 as hundreds of thousands of Canadians don the iconic Canadian attire all to honour dad and end prostate cancer.
More

The Finger – A tried and true method to save lives

TORONTO, CANADA (May 8, 2018) – Every day, more and more methods to detect prostate cancer are being explored, but the tried and true methods of a digital rectal examination (DRE) – where a healthcare professional inserts a gloved finger into the rectum to check for abnormalities, paired with a blood test known as the prostate-specific antigen (PSA) test – which you can get through your family doctor, are still the long-standing proven ways to save a life.
More


Click here for news archive